Improving Lithium Therapeutics by Crystal Engineering of Novel Ionic Cocrystals

[Image: see text] Current United States Food and Drug Administration (FDA)-approved lithium salts are plagued with a narrow therapeutic window. Recent attempts to find alternative drugs have identified new chemical entities, but lithium’s polypharmacological mechanisms for treating neuropsychiatric...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Adam J., Kim, Seol-Hee, Duggirala, Naga K., Jin, Jingji, Wojtas, Lukasz, Ehrhart, Jared, Giunta, Brian, Tan, Jun, Zaworotko, Michael J., Shytle, R. Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2013
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850245/
https://www.ncbi.nlm.nih.gov/pubmed/24191685
http://dx.doi.org/10.1021/mp400571a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850245/
https://www.ncbi.nlm.nih.gov/pubmed/24191685
http://dx.doi.org/10.1021/mp400571a

Ejemplares similares